Secondary renal amyloidosis associated with asbestos-related pleuropulmonary diseases

Abstract

Here, we present a 67-year-old Japanese man who developed insidious-onset nephrotic syndrome. He had a history of occupational asbestos exposure for about 8 years during his 30s, and was found to have pleural effusion 3 years before his present illness. At that time, repeated cytology testing of his pleural effusion found no malignant cells, and pleural biopsy found fibrous pleuritis without evidence of malignant mesothelioma. Percutaneous kidney biopsy found massive deposits of AA-type amyloid in the glomeruli, small arteries, and medulla. Computed tomography showed a calcified mass in the right lower lung that was positive for 67Ga uptake, but transbronchial lung biopsy and bronchoalveolar lavage found no evidence of malignancy. He was diagnosed with rounded atelectasis and diffuse pleural thickening. As these benign asbestos-related diseases have no standard treatment, we administered low-dose angiotensin II receptor blocker to preserve kidney function. Unfortunately, his nephrotic syndrome persists, with progressive chronic kidney failure. Kidney involvement in patients with asbestos-related disease is rare. To our knowledge, this is the first case to present with secondary amyloidosis. Kidney biopsy should be considered for patients with existing asbestos-related pleuropulmonary diseases who have urinary abnormalities or renal dysfunction, to clarify the incidence and pathophysiology of renal manifestations.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Solbes E, Harper RW. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. J Investig Med. 2018;66:721–7.

    Article  Google Scholar 

  2. 2.

    Fujimoto N, Gemba K, Aoe K, et al. Clinical investigation of benign asbestos pleural effusion. Pulm Med. 2015;2015:416179.

    Article  Google Scholar 

  3. 3.

    Kwak KM, Paek D, Hwang SS, Ju YS. Estimated future incidence of malignant mesothelioma in South Korea: projection from 2014 to 2033. PLoS ONE. 2017;12:e0183404.

    Article  Google Scholar 

  4. 4.

    Berry G. Mortality of workers certified by pneumoconiosis medical panels as having asbestosis. Br J Ind Med. 1981;38:130–7.

    CAS  PubMed Central  Google Scholar 

  5. 5.

    Fujimoto N, Kato K, Usami I, et al. Asbestos related diffuse pleural thickening. Respiration. 2014;88:277–84.

    CAS  Article  Google Scholar 

  6. 6.

    Husain AN, Colby T, Ordonez N, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2012;136:1–21.

    Google Scholar 

  7. 7.

    Wu D, Hiroshima K, Matsumoto S, et al. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis. Am J Clin Pathol. 2013;139:39–46.

    CAS  Article  Google Scholar 

  8. 8.

    Peto J, Doll R, Hermon C, et al. Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg. 1985;29:305–55.

    CAS  Google Scholar 

  9. 9.

    Becklake M, Case BW. Fiber burden and asbestos-related lung disease: determinants of dose-response relationships. Am J Respir Crit Care Med. 1994;150:1488–92.

    CAS  Article  Google Scholar 

  10. 10.

    Schroeter NJ, Rushing DA, Parker JP, Beltaos E. Minimal-change nephrotic syndrome associated with malignant mesothelioma. Arch Intern Med. 1986;146:1834–6.

    CAS  Article  Google Scholar 

  11. 11.

    Venzano C, Di Marco E, Garbero M, et al. Nephrotic syndrome associated with pleural mesothelioma. An unusual paraneoplastic event. Recenti Prog Med. 1990;81:325–6.

    CAS  Google Scholar 

  12. 12.

    Tanaka S, Oda H, Satta H, et al. Nephrotic syndrome associated with malignant mesothelioma. Nephron. 1994;67:510–1.

    CAS  Article  Google Scholar 

  13. 13.

    Farmer CK, Goldsmith DJ. Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma. Postgrad Med J. 2001;77:333–4.

    CAS  Article  Google Scholar 

  14. 14.

    Li JY, Yong TY, Kuss BJ, et al. Malignant pleural mesothelioma with associated minimal change disease and acute renal failure. Ren Fail. 2010;32:1012–5.

    Article  Google Scholar 

  15. 15.

    Dogan M, Ozal G, Savas B, et al. Malign peritoneal mesothelioma with nephrotic syndrome. Bratisl Lek Listy. 2012;113:43–5.

    CAS  Google Scholar 

  16. 16.

    Suzuki S, Toyoshima M, Nihashi F, et al. An autopsy case of malignant pleural mesothelioma associated with nephrotic syndrome. Intern Med. 2014;53:243–6.

    Article  Google Scholar 

  17. 17.

    Tsukamoto Y, Otsuki T, Hao H, et al. Epithelioid pleural mesothelioma concurrently associated with miliary pulmonary metastases and minimal change nephrotic syndrome: a hitherto undescribed case. Pathol Res Pract. 2015;211:1014–9.

    Article  Google Scholar 

  18. 18.

    Briggs JH, Singleton WG, Burke MM, et al. Amyloidosis presenting as bilateral transudative pleural effusions with normal cardiac investigations: a case report. Cases J. 2009;2:6963.

    Article  Google Scholar 

  19. 19.

    Nakano T, Endo S, Tetsuka K, Fukushima N. Asymptomatic localized pleural amyloidosis mimicking malignant pleural mesothelioma: report of a case. J Thorac Dis. 2016;8:E157–E160160.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Marla Brunker of Edanz Group (https://www.edanzgroup.com) for careful reading and editing of a draft of our manuscript.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kosuke Masutani.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient described in this case report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shibata, R., Ozaki, T., Tada, K. et al. Secondary renal amyloidosis associated with asbestos-related pleuropulmonary diseases. CEN Case Rep (2020). https://doi.org/10.1007/s13730-020-00493-7

Download citation

Keywords

  • AA amyloid
  • Kidney biopsy
  • Latent period
  • Malignant mesothelioma
  • Nephrotic syndrome